Pharmafile Logo
Pharmafocus logo
Advanced Search
Zaltrap image

Sanofi’s Zaltrap data published

October 8, 2012
Research and Development, Sales and Marketing Erbitux, Sanofi, Stivarga, Zaltrap, avastin

Detailed data from the Phase III trial of Sanofi’s newly-licenced anti-VEGF cancer drug Zaltrap, co-marketed with Regeneron, has been published. …

News
jim_chiltern

Chiltern announces new chief executive

October 8, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Jim Esinhart, chiltern

Contract research organisation Chiltern International has announced a successor to chief executive Glenn Kerkhof, who is stepping down to be …

Appointment
Lucentis image

NICE does Lucentis U-turn

October 5, 2012
Sales and Marketing Lucentis, NICE, Novartis, Roche, avastin

NICE has done a U-turn over its previous verdict on Novartis’ Lucentis, now recommending the drug in draft guidance to …

News
Digital awards image

Vernon named Digital Pioneer at PM Society awards

October 5, 2012
Medical Communications Creative Lynx, GSK, PM Society Digital Awards, digital

A range of innovative digital programmes created by UK pharma companies and agencies were recognised at last night’s PM Society …

News
BHIVA image

NHS under fire for ‘misdiagnosis’

October 5, 2012
Sales and Marketing BHIVA, HIV, NHS

Patients with HIV infections are going unnoticed by the NHS while those with rare diseases are often being misdiagnosed. These …

News
screen_shot_2012-10-05_at_09

Appointments and moves at the BIA

October 5, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, BioIndustry Association

The BioIndustry Association (BIA) has appointed Harren Jhoti and Will West to its Board of directors at its Annual General …

Appointment
text

Louise Tamblin rejoins Kantar Health

October 4, 2012
Kantar Health, Louise Tamblin

Healthcare-focused consultancy and marketing firm Kantar Health has named Louise Tamblin as group director. Most recently Tamblin was head of …

Appointment

NHS patient care ‘will worsen’

October 4, 2012
Sales and Marketing A&E, MRSA, NHS, king's fund

Patient care will worsen over the next few years and the NHS will not meet its £20 billion productivity target …

News

Sanofi acquires leading Colombian firm

October 4, 2012
Sales and Marketing Columbia, Genfar, Latin America, Sanofi

Sanofi is expanding its presence in Latin American with the acquisition of a Colombian pharma company. Genfar is headquartered in …

News
114053815_tovey_341562c

GW Pharmaceuticals hires chief operating officer

October 4, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Chris Tovey, GW Pharmaceuticals

GW Pharmaceuticals has announced the appointment of Christopher John Tovey to the newly created position of chief operating officer. Tovey, …

Appointment

Seebri Breezhaler approved in Europe

October 4, 2012
Sales and Marketing COPD, Novartis, Relvar, Seebri Breezhaler, Tudorza

Novartis has been given approval in Europe for its Seebri Breezhaler to be used as maintenance treatment for chronic obstructive …

News
BMS image

Patent losses force change for Sanofi

October 3, 2012
Sales and Marketing Avapro, BMS, Plavix, Sanofi, patent loss

Patent expiries are behind the decision by Sanofi and Bristol-Myers Squibb to radically restructure their long-term corporate alliance. The loss …

News
dame_christine_beasley_282x212

Non-executive directors of NHS Trust appointed

October 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christine Beasley, NHS, Sarah Harkness

Christine Beasley and Sarah Harkness have been confirmed as non-executive directors of the NHS Trust Development Authority.  Ms Beasley (pictured) …

Appointment

Quality issues prompt Sanofi typhoid vaccine recall

October 3, 2012
Manufacturing and Production Sanofi, Typhen Vi, recall

Sanofi has recalled several lots of its typhoid fever vaccine Typhim Vi on fears that a quality defect could compromise …

News
Bayer image

Bayer signs endometriosis pact

October 3, 2012
Research and Development, Sales and Marketing Bayer, Evotec, endometriosis

Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …

News
Roche and GSK image

Is it really safety first?

October 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Les Rose, Roche

The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …

Feature

Catalent and CTC Partner to Help Korean Pharma Take Their Products to Western Markets

October 2, 2012
Research and Development

Somerset, NJ, September 13, 2012 – Catalent Pharma Solutions and CTC Bio have entered into a collaboration to provide optimal …

News
Press release

Catalent Enters Into Commerical Supply Agreement with Vivus for Qsymia™ Once-Daily Combination Extended-Release Capsules

October 2, 2012
Manufacturing and Production

Somerset, NJ, October 1, 2012 – Catalent Pharma Solutions announced that it has entered into a Supply Agreement with VIVUS, …

News
Press release
votrient image

Survival boost for Votrient in mRCC

October 2, 2012
Research and Development, Sales and Marketing GSK, Nexavar, Pfizer, Sutent, Votrient

GlaxoSmithKline’s renal cell carcinoma drug Votrient has proved itself non-inferior to a bitter rival, Pfizer’s Sutent, in terms of progression-free …

News

Government launches Healthwatch England

October 2, 2012
Sales and Marketing HealthWatch, NHS, government

The government has launched Healthwatch England, a new statutory body whose role is to ensure the public’s voice is heard …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026